1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Dipenkumar Modi: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma AutoSCT OR CAR T-cell Therapy, GDP, Epcoritamab - Large Cell Lymphoma, Diffuse, Relapsed Cancer | Phase 2 | Recruiting | Dipenkumar Modi | 35 | 2023-10-31 | 2026-07-10 |
Lymphoma, Large B-Cell, Diffuse (1) · Neoplasms (1) · Recurrence (1)
Automobiles (1) · Guanosine Diphosphate (1) · Immunotherapy, Adoptive (1) · Receptors, Chimeric Antigen (1) · Transplantation, Autologous (1)
United States (1)